Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer

BACKGROUND: Proof of the clinical utility of a biomarker is when its use informs a management decision and improves patient outcomes relative to when it is not. OBJECTIVE: To model the clinical benefit of the nuclear-localized AR-V7 test for men with progressing metastatic castration-resistant prost...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur Urol
Prif Awduron: Graf, Ryon P., Hullings, Melanie, Barnett, Ethan S., Carbone, Emily, Dittamore, Ryan, Scher, Howard I.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7472426/
https://ncbi.nlm.nih.gov/pubmed/31648903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.08.020
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg